169 related articles for article (PubMed ID: 20686226)
1. Panax notoginseng saponins attenuate atherogenesis accelerated by zymosan in rabbits.
Liu Y; Zhang HG; Jia Y; Li XH
Biol Pharm Bull; 2010; 33(8):1324-30. PubMed ID: 20686226
[TBL] [Abstract][Full Text] [Related]
2. Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action.
Zhang YG; Zhang HG; Zhang GY; Fan JS; Li XH; Liu YH; Li SH; Lian XM; Tang Z
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1238-44. PubMed ID: 18637019
[TBL] [Abstract][Full Text] [Related]
3. Panax notoginseng saponins inhibit Zymosan A induced atherosclerosis by suppressing integrin expression, FAK activation and NF-κB translocation.
Yuan Z; Liao Y; Tian G; Li H; Jia Y; Zhang H; Tan Z; Li X; Deng W; Liu K; Zhang Y
J Ethnopharmacol; 2011 Oct; 138(1):150-5. PubMed ID: 21924337
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway.
Fan J; Liu D; He C; Li X; He F
J Ethnopharmacol; 2016 Nov; 192():423-430. PubMed ID: 27620662
[TBL] [Abstract][Full Text] [Related]
5. Panax notoginseng saponins attenuate atherosclerosis via reciprocal regulation of lipid metabolism and inflammation by inducing liver X receptor alpha expression.
Fan JS; Liu DN; Huang G; Xu ZZ; Jia Y; Zhang HG; Li XH; He FT
J Ethnopharmacol; 2012 Aug; 142(3):732-8. PubMed ID: 22683903
[TBL] [Abstract][Full Text] [Related]
6. Protective Effect of Panax Notoginseng Saponins on Apolipoprotein-E-deficient Atherosclerosis-prone Mice.
Yang H; Liu Z; Hu X; Liu X; Gui L; Cai Z; Dai C
Curr Pharm Des; 2022; 28(8):671-677. PubMed ID: 35088656
[TBL] [Abstract][Full Text] [Related]
7. Effects of panax notoginseng saponin on the pathological ultrastructure and serum IL-6 and IL-8 in pulmonary fibrosis in rabbits.
Zhang J; Li Q; Shao Q; Song J; Zhou B; Shu P
J Cell Biochem; 2018 Nov; 119(10):8410-8418. PubMed ID: 29932250
[TBL] [Abstract][Full Text] [Related]
8. Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats.
Du YG; Wang LP; Qian JW; Zhang KN; Chai KF
Chin J Integr Med; 2016 Dec; 22(12):910-917. PubMed ID: 26712211
[TBL] [Abstract][Full Text] [Related]
9. Panax notoginseng saponins promote endothelial progenitor cell mobilization and attenuate atherosclerotic lesions in apolipoprotein E knockout mice.
Liu Y; Hao F; Zhang H; Cao D; Lu X; Li X
Cell Physiol Biochem; 2013; 32(4):814-26. PubMed ID: 24080960
[TBL] [Abstract][Full Text] [Related]
10. Human apolipoprotein A-I exerts a prophylactic effect on high-fat diet-induced atherosclerosis via inflammation inhibition in a rabbit model.
Li J; Wang W; Han L; Feng M; Lu H; Yang L; Hu X; Shi S; Jiang S; Wang Q; Ye L
Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):149-158. PubMed ID: 28069582
[TBL] [Abstract][Full Text] [Related]
11.
Zhao Y; Zheng J; Yu Y; Wang L
Biomed Res Int; 2018; 2018():9239354. PubMed ID: 30151392
[No Abstract] [Full Text] [Related]
12. Panax notoginseng saponins provide neuroprotection by regulating NgR1/RhoA/ROCK2 pathway expression, in vitro and in vivo.
Shi X; Yu W; Yang T; Liu W; Zhao Y; Sun Y; Chai L; Gao Y; Dong B; Zhu L
J Ethnopharmacol; 2016 Aug; 190():301-12. PubMed ID: 27288754
[TBL] [Abstract][Full Text] [Related]
13. 20(
Liu C; Feng R; Zou J; Xia F; Wan JB
Molecules; 2019 Oct; 24(20):. PubMed ID: 31623159
[TBL] [Abstract][Full Text] [Related]
14. Intervention Effects of Atorvastatin Combined with
Jiang QF; Huang MY; Wu KY; Weng JL; Deng RG; Xu XJ; Xu JP; Jiang T
Pharmacogn Mag; 2017; 13(51):430-438. PubMed ID: 28839368
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology-based identification of protective mechanism of Panax Notoginseng Saponins on aspirin induced gastrointestinal injury.
Zhu B; Zhang W; Lu Y; Hu S; Gao R; Sun Z; Chen X; Ma J; Guo S; Du S; Li P
Biomed Pharmacother; 2018 Sep; 105():159-166. PubMed ID: 29857294
[TBL] [Abstract][Full Text] [Related]
16. Panax notoginseng saponins suppress lipopolysaccharide-induced barrier disruption and monocyte adhesion on bEnd.3 cells via the opposite modulation of Nrf2 antioxidant and NF-κB inflammatory pathways.
Hu S; Liu T; Wu Y; Yang W; Hu S; Sun Z; Li P; Du S
Phytother Res; 2019 Dec; 33(12):3163-3176. PubMed ID: 31468630
[TBL] [Abstract][Full Text] [Related]
17. UPLC/Q-TOFMS-Based Metabolomics Studies on the Protective Effect of Panax notoginseng Saponins on Alcoholic Liver Injury.
Liu F; Bai X; Ding RB; Hu YJ; Su H; Wan JB
Am J Chin Med; 2015; 43(4):695-714. PubMed ID: 26133752
[TBL] [Abstract][Full Text] [Related]
18.
Luo H; Vong CT; Tan D; Zhang J; Yu H; Yang L; Zhang C; Luo C; Zhong Z; Wang Y
Am J Chin Med; 2021; 49(4):925-939. PubMed ID: 33829964
[No Abstract] [Full Text] [Related]
19. Panax notoginseng saponins decrease cholesterol ester via up-regulating ATP-binding cassette transporter A1 in foam cells.
Jia Y; Li ZY; Zhang HG; Li HB; Liu Y; Li XH
J Ethnopharmacol; 2010 Oct; 132(1):297-302. PubMed ID: 20727959
[TBL] [Abstract][Full Text] [Related]
20. [Effect of Panax notoginseng saponins on cytokines in liver fibrosis rats].
Jiang H; Wang YZ; Liu XC; Xue X
Zhong Yao Cai; 2013 Jul; 36(7):1123-7. PubMed ID: 24417151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
